参考文献/References:
［1］ 黄海茵，韩明权.克服肺癌耐药性的研究进展［J］.肿瘤防治研究，2002，29（5）：422-424.
［2］ 喻龙姗.胃癌多药耐药机制研究进展［J］.安徽医科大学学报，2013，48（4）：449-452.
［3］ ZHENG T，WANG J，CHEN X，et al.Role of microRNA in anticancer drug resistance［J］.Int J Cancer，2010，126(1): 2-10.
［4］ BUSHATI N，COHEN S M. MicroRNA functions［J］.Annu Rev Cell Dev Biol，2007，23:175-205.
［5］ CHAN S P，RAMASWAMY G，CHOI E Y，et al.Identification of specific let-7 microRNA binding complexes in Caenorhabditis elegans［J］.RNA，2008，14(10): 2104-2114.
［6］ JEONG Y，XIE Y，LEE W，et al.Research resource: diagnostic and therapeutic potential of nuclear receptor expression in lung cancer［J］.Mol Endocrinol，2012，26(8):1443-1454.
［7］ CHO W C. OncomiRs: the discovery and progress of microRNAs in cancers［J］.Mol Cancer，2007，6: 60.
［8］ SCHETTER A J，LEUNG S Y，SOHN J J，et al.MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma［J］.JAMA，2008，299(4): 425-436.
［9］ 李文静.MiRNAs与肿瘤化学治疗耐药［J］.国际检验医学杂志，2011，32(21):2481-2483.
［10］ GANDELLINI P，PROFUMO V，FOLINI M，et al.MicroRNAs as new therapeutic targets and tools in cancer［J］.Expert Opin Ther Targets，2011，15(3):265-279.
［11］ TRANG P，WEIDHAAS J B，SLACK F J.MicroRNAs as potential cancer therapeutics［J］.Oncogene，2008，27(Suppl 2):S52-S57.
［12］ 曹翊雄，戴崇文，张广森.K562细胞及其耐药细胞株K562/A02细胞白血病耐药相关microRNA筛选［J］.中华血液学杂志，2010，31（6）：361-365.
［13］ PAN Y Z，MORRIS M E，YU A M. MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells［J］.Mol Pharmacol，2009，75(6):1374-1379.
［14］ LEWIS B P，BURGE C B，BARTEL D P.Conserved seed pairing,often flanked by adenosines,indicates that thousands of human genes are microRNA targets［J］.Cell，2005，120(1):15-20.
［15］ FRIEDMAN R C，FARH K K，BURGE C B，et al.Most mammalian mRNAs are conserved targets of microRNAs［J］.Genome Res， 2009，19(1):92-105.
［16］ YANG L，BELAGULI N，BERGER D H.MicroRNA and colorectal cancer［J］.World J Surg，2009，33(4):638-646.
［17］ METZLER M，WILDA M，BUSCH K，et al.High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma［J］.Genes Chromosomes Cancer，2004，39(2):167-169.
［18］ ZHANG H，LI M，HAN Y，et al.Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma［J］.Dig Dis Sci，2010，55(9):2545-2551.
［19］ XIAO J，PENG F，YU C，et al.MicroRNA-137 modulates pancreatic cancer cells tumor growth,invasion and sensitivity to chemotherapy［J］.Int J Clin Exp Pathol，2014，7(11):7442-7450.
［20］ MATUSZCAK C，HAIER J，HUMMEL R，et al.MicroRNAs:promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential［J］.World J Gastroenterol，2014，20(38):13658-13666.
相似文献/References:
[1]李勇莉,高福莲.mdr1介导的多药耐药及其逆转的研究进展 [J].新乡医学院学报,2006,23(03):000.
[2]王煜霞,姬明丽,李生莹,等.c-erbB22 的表达与非小细胞肺癌多药耐药的关系[J].新乡医学院学报,2006,23(05):469.
[3]王志慧,梁文辉,原志庆,等.缺氧诱导因子-2α对乳腺癌细胞多药耐药的影响[J].新乡医学院学报,2018,35(11):961.[doi:10.7683/xxyxyxb.2018.11.004]
WANG Zhi-hui,LIANG Wen-hui,YUAN Zhi-qing,et al.Effect of hypoxia inducible factor-2α induce multidrug resistance in breast cancer[J].Journal of Xinxiang Medical University,2018,35(3):961.[doi:10.7683/xxyxyxb.2018.11.004]
[4]何社红,薛聪玲.谷胱甘肽转移酶-π与卵巢癌多药耐药的关系[J].新乡医学院学报,2017,34(4):320.[doi:10.7683/xxyxyxb.2017.04.020]
HE She-hong,XUE Cong-ling.Relationship between glutathione S-transferase-π and multidrug resistance of ovarian cancer[J].Journal of Xinxiang Medical University,2017,34(3):320.[doi:10.7683/xxyxyxb.2017.04.020]
[5]何社红,薛聪玲.蛋白激酶C活性与卵巢癌多药耐药性的相关性[J].新乡医学院学报,2017,34(7):660.[doi:10.7683/xxyxyxb.2017.07.029]
HE She-hong,XUE Cong-ling.Correlation between protein kinase C activity and multidrug resistance in ovarian cancer[J].Journal of Xinxiang Medical University,2017,34(3):660.[doi:10.7683/xxyxyxb.2017.07.029]